{"id":904619,"date":"2025-11-03T18:13:45","date_gmt":"2025-11-03T23:13:45","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/tela-bio-appoints-william-plovanic-to-board-of-directors\/"},"modified":"2025-11-03T18:13:45","modified_gmt":"2025-11-03T23:13:45","slug":"tela-bio-appoints-william-plovanic-to-board-of-directors","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/tela-bio-appoints-william-plovanic-to-board-of-directors\/","title":{"rendered":"TELA Bio Appoints William Plovanic to Board of Directors"},"content":{"rendered":"
\n

MALVERN, Pa., Nov. 03, 2025 (GLOBE NEWSWIRE) — MALVERN, Pa., November 3, 2025 (GLOBE NEWSWIRE) \u2014 TELA Bio, Inc. (\u201cTELA\u00a0Bio\u201d) (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced the appointment of William (\u201cBill\u201d) Plovanic, CFA, to its Board of Directors.<\/p>\n

Mr. Plovanic brings a distinctive combination of capital markets expertise and operational leadership in medical technology. He currently serves as Managing Director, Healthcare Equity Research at Canaccord Genuity. From 2016 to 2021, he held C-level operating and board roles at Obalon Therapeutics, a formerly publicly traded medical device company, providing first-hand experience in corporate strategy and commercial execution.<\/p>\n

\u201cWe are pleased to welcome Bill to our Board,\u201d said Antony Koblish, Co-founder and Chief Executive Officer of TELA Bio. \u201cHe bridges the worlds of Wall Street and operating leadership. His understanding of the capital markets \u2014paired with direct experience running a publicly held med-tech company\u2014will help to further strengthen our strategy and drive long-term shareholder value.\u201d<\/p>\n

\u201cI\u2019m honored to join TELA Bio at this pivotal stage,\u201d said Mr. Plovanic. \u201cThe company stands out as a leader redefining what is possible in soft-tissue reconstruction.\u201d<\/p>\n

\n About<\/strong>
\n William<\/strong>
\n Plovanic,<\/strong>
\n CFA<\/strong>\n <\/p>\n

Mr. Plovanic currently serves as Managing Director, Healthcare Equity Research at Canaccord Genuity. He has more than 25 years of experience spanning capital markets, corporate strategy, and medical device operations.<\/p>\n

From 2016 to 2021, Mr. Plovanic held a range of C-level operating and board roles at Obalon Therapeutics (formerly, Nasdaq: OBLN), including Chief Executive Officer, President and Chief Financial Officer. Obalon Therapeutics was a publicly traded company with a highly differentiated technology and service solution for weight loss. Earlier in his career, he held senior equity research positions at First Albany and Canaccord Genuity, specializing in medical technology and life sciences.<\/p>\n

Mr. Plovanic earned a Bachelor of Science in Finance from Bradley University and is a Chartered Financial Analyst (CFA) Charterholder.<\/p>\n

\n About<\/strong>
\n TELA<\/strong>
\n Bio,<\/strong>
\n Inc.<\/strong>\n <\/p>\n

TELA Bio, Inc. (NASDAQ: TELA) is a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy. The Company is committed to providing surgeons with advanced, economically e\ufb00ective soft-tissue reconstruction solutions that leverage the patient’s natural healing response while minimizing long-term exposure to permanent synthetic materials. For more information, visit www.telabio.com<\/u><\/a>.<\/p>\n

\n Caution<\/strong>
\n Regarding<\/strong>
\n Forward-Looking<\/strong>
\n Statements<\/strong>\n <\/p>\n

This press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Words such as “may,” “might,” “will,” “should,” “believe,” “expect,” “anticipate,” “estimate,” “continue,” “predict,” “forecast,” “project,” “plan,” “intend” or similar expressions, or statements regarding intent, belief, or current expectations are forward-looking statements and reflect the current beliefs of TELA Bio’s management. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and other factors that could cause actual results and events to di\ufb00er materially and adversely from those indicated by such forward-looking statements.\u00a0These risks and uncertainties are described more fully in the “Risk Factors” section and elsewhere in our filings with the Securities and Exchange Commission and available at www.sec.gov,<\/a> including in our Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. Any forward-looking statements that we make in this announcement speak only as of the date of this press release, and TELA Bio assumes no obligation to update forward-looking statements whether as a result of new information, future events or otherwise after the date of this press release, except as required under applicable law.<\/p>\n

\n Investor<\/strong>
\n Contact
<\/strong>Louisa Smith
ir@telabio.com<\/a><\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

MALVERN, Pa., Nov. 03, 2025 (GLOBE NEWSWIRE) — MALVERN, Pa., November 3, 2025 (GLOBE NEWSWIRE) \u2014 TELA Bio, Inc. (\u201cTELA\u00a0Bio\u201d) (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced the appointment of William (\u201cBill\u201d) Plovanic, CFA, to its Board of Directors. Mr. Plovanic brings a distinctive combination of capital markets expertise and operational leadership in medical technology. He currently serves as Managing Director, Healthcare Equity Research at Canaccord Genuity. From 2016 to 2021, he held C-level operating and board roles at Obalon Therapeutics, a formerly publicly traded medical device company, providing first-hand experience in corporate strategy and commercial execution. \u201cWe are pleased to welcome Bill to our Board,\u201d said Antony Koblish, Co-founder and … <\/p>\n

Continue reading “TELA Bio Appoints William Plovanic to Board of Directors”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-904619","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nTELA Bio Appoints William Plovanic to Board of Directors - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tela-bio-appoints-william-plovanic-to-board-of-directors\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"TELA Bio Appoints William Plovanic to Board of Directors - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"MALVERN, Pa., Nov. 03, 2025 (GLOBE NEWSWIRE) — MALVERN, Pa., November 3, 2025 (GLOBE NEWSWIRE) \u2014 TELA Bio, Inc. (\u201cTELA\u00a0Bio\u201d) (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced the appointment of William (\u201cBill\u201d) Plovanic, CFA, to its Board of Directors. Mr. Plovanic brings a distinctive combination of capital markets expertise and operational leadership in medical technology. He currently serves as Managing Director, Healthcare Equity Research at Canaccord Genuity. From 2016 to 2021, he held C-level operating and board roles at Obalon Therapeutics, a formerly publicly traded medical device company, providing first-hand experience in corporate strategy and commercial execution. \u201cWe are pleased to welcome Bill to our Board,\u201d said Antony Koblish, Co-founder and … Continue reading "TELA Bio Appoints William Plovanic to Board of Directors"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/tela-bio-appoints-william-plovanic-to-board-of-directors\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-03T23:13:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2NzYzMSM3MjQwNjAzIzIxODAxMzk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tela-bio-appoints-william-plovanic-to-board-of-directors\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tela-bio-appoints-william-plovanic-to-board-of-directors\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"TELA Bio Appoints William Plovanic to Board of Directors\",\"datePublished\":\"2025-11-03T23:13:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tela-bio-appoints-william-plovanic-to-board-of-directors\\\/\"},\"wordCount\":592,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tela-bio-appoints-william-plovanic-to-board-of-directors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU2NzYzMSM3MjQwNjAzIzIxODAxMzk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tela-bio-appoints-william-plovanic-to-board-of-directors\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tela-bio-appoints-william-plovanic-to-board-of-directors\\\/\",\"name\":\"TELA Bio Appoints William Plovanic to Board of Directors - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tela-bio-appoints-william-plovanic-to-board-of-directors\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tela-bio-appoints-william-plovanic-to-board-of-directors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU2NzYzMSM3MjQwNjAzIzIxODAxMzk=\",\"datePublished\":\"2025-11-03T23:13:45+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tela-bio-appoints-william-plovanic-to-board-of-directors\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tela-bio-appoints-william-plovanic-to-board-of-directors\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tela-bio-appoints-william-plovanic-to-board-of-directors\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU2NzYzMSM3MjQwNjAzIzIxODAxMzk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU2NzYzMSM3MjQwNjAzIzIxODAxMzk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tela-bio-appoints-william-plovanic-to-board-of-directors\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"TELA Bio Appoints William Plovanic to Board of Directors\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"TELA Bio Appoints William Plovanic to Board of Directors - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/tela-bio-appoints-william-plovanic-to-board-of-directors\/","og_locale":"en_US","og_type":"article","og_title":"TELA Bio Appoints William Plovanic to Board of Directors - Market Newsdesk","og_description":"MALVERN, Pa., Nov. 03, 2025 (GLOBE NEWSWIRE) — MALVERN, Pa., November 3, 2025 (GLOBE NEWSWIRE) \u2014 TELA Bio, Inc. (\u201cTELA\u00a0Bio\u201d) (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced the appointment of William (\u201cBill\u201d) Plovanic, CFA, to its Board of Directors. Mr. Plovanic brings a distinctive combination of capital markets expertise and operational leadership in medical technology. He currently serves as Managing Director, Healthcare Equity Research at Canaccord Genuity. From 2016 to 2021, he held C-level operating and board roles at Obalon Therapeutics, a formerly publicly traded medical device company, providing first-hand experience in corporate strategy and commercial execution. \u201cWe are pleased to welcome Bill to our Board,\u201d said Antony Koblish, Co-founder and … Continue reading \"TELA Bio Appoints William Plovanic to Board of Directors\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/tela-bio-appoints-william-plovanic-to-board-of-directors\/","og_site_name":"Market Newsdesk","article_published_time":"2025-11-03T23:13:45+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2NzYzMSM3MjQwNjAzIzIxODAxMzk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tela-bio-appoints-william-plovanic-to-board-of-directors\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tela-bio-appoints-william-plovanic-to-board-of-directors\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"TELA Bio Appoints William Plovanic to Board of Directors","datePublished":"2025-11-03T23:13:45+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tela-bio-appoints-william-plovanic-to-board-of-directors\/"},"wordCount":592,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tela-bio-appoints-william-plovanic-to-board-of-directors\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2NzYzMSM3MjQwNjAzIzIxODAxMzk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tela-bio-appoints-william-plovanic-to-board-of-directors\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/tela-bio-appoints-william-plovanic-to-board-of-directors\/","name":"TELA Bio Appoints William Plovanic to Board of Directors - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tela-bio-appoints-william-plovanic-to-board-of-directors\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tela-bio-appoints-william-plovanic-to-board-of-directors\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2NzYzMSM3MjQwNjAzIzIxODAxMzk=","datePublished":"2025-11-03T23:13:45+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tela-bio-appoints-william-plovanic-to-board-of-directors\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/tela-bio-appoints-william-plovanic-to-board-of-directors\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tela-bio-appoints-william-plovanic-to-board-of-directors\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2NzYzMSM3MjQwNjAzIzIxODAxMzk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2NzYzMSM3MjQwNjAzIzIxODAxMzk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tela-bio-appoints-william-plovanic-to-board-of-directors\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"TELA Bio Appoints William Plovanic to Board of Directors"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/904619","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=904619"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/904619\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=904619"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=904619"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=904619"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}